Sclerosing Angiomatoid Nodular Transformation (SANT) of the spleen: Case report and review of the literature  by Falk, Gavin A. et al.
S
r
G
a
b
a
A
R
A
A
K
S
S
1
s
d
a
a
2
i
h
o
b
3
o
t
m
d
ﬂ
2
hCASE  REPORT  –  OPEN  ACCESS
International Journal of Surgery Case Reports 3 (2012) 492– 500
Contents lists available at SciVerse ScienceDirect
International  Journal  of  Surgery  Case  Reports
j ourna l ho me  pa ge: www.elsev ier .com/ locate / i j scr
clerosing  Angiomatoid  Nodular  Transformation  (SANT)  of  the  spleen:  Case
eport  and  review  of  the  literature
avin  A.  Falka,∗, Nishank  P.  Nooli a, Gareth  Morris-Stiff a, Thomas  P.  Plesecb, Steven  Rosenblatta
Department of General Surgery, Cleveland Clinic Foundation, Digestive Disease Institute, 9500 Euclid Avenue, Cleveland, OH 44195, United States
Department of Anatomic Pathology, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, United States
 r  t  i  c  l  e  i  n  f  o
rticle history:
eceived 12 May  2012
ccepted  30 June 2012
vailable online 7 July 2012
eywords:
pleen
plenectomy
a  b  s  t  r  a  c  t
INTRODUCTION:  Sclerosing  Angiomatoid  Nodular  Transformation  of the  spleen  (SANT)  is a rare  benign
vascular  lesion  of  the  spleen  with  extensive  sclerosis  and  unknown  etiology.
PRESENTATION OF  CASE:  We  report  a new  case  of  SANT  of  the  spleen  found  in a 53-year-old  female
following  detection  of  a  splenic  mass  on a routine  computed  tomography  (CT).  The  patient  underwent  an
uncomplicated  laparoscopic  splenectomy  and  the  specimen  was  sent  for  histopathologic  examination.
DISCUSSION: A  review  of the  97  reported  cases  of SANT  found  in the  literature  was  undertaken.  There
were  43  males  and  54  females  with  a  median  age  of 46  years  (range:  11–82  years).  SANT  is classically
considered  to be  a female  predominant  disease,  however  44.3%  of  reported  case  were  male  and  the
gender  predilection  may  soon  be  neutralized  as  more  cases  are  reported.  65 of  the  97  (67%)  patients  were
in  30–60  year  age  group.  The  majority  of  lesions  (n =  50)  were  incidentally  found on  imaging,  and  for
those  patients  presenting  with  symptoms,  abdominal  pain  (n  = 18)  was  the  predominant  symptom.
CONCLUSION:  The  diagnosis  of  SANT  should  be  considered  in  any  patient  presenting  with  a splenic  lesion
that  contains  an  angiomatoid  or inﬂammatory  component.  As  the  differential  diagnosis  for  SANT  includes
malignant  pathologies,  and  currently  no  reliable  diagnostic  radiological  feature  has  been  identiﬁed  to
differentiate  between  these  conditions,  SANT  will continue  to  be diagnosed  on  the  basis of surgical
histopathology.
gical © 2012 Sur
. Introduction
Sclerosing Angiomatoid Nodular Transformation (SANT) of the
pleen is a rare benign vascular lesion with extensive sclerosis ﬁrst
escribed by Martel and colleagues in 2004.1 In this paper we  report
 case of SANT of the spleen managed at our institution, and present
 review of 97 other cases found in the literature.
. Presentation of case
A 53 year old Caucasian female was referred to our department
n consideration of splenectomy. She had been under the care of the
ematology department following the detection of a splenic mass
n a routine computed tomography (CT) scan performed for chronic
ack pain (Fig. 1). An ultrasound scan at that time demonstrated a
.6 × 3.5 × 3.5 cm hypoechoic splenic density, and a magnetic res-
nance imaging (MRI) scan (Fig. 2) conﬁrmed the mass within
he inferior spleen demonstrating diffuse heterogeneous enhance-
ent. At this time the differential diagnosis included Gaucher’s
isease, sarcoid or a low-grade lymphoma. Bone marrow biopsy,
ow cytometry, chromosome analysis and angiotension converting
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enzyme levels were normal, and the above differential diagnoses
ruled out.
Over a three year period the splenic mass increased in diam-
eter to 5.9 cm and the referring hematologist was concerned for
the possibility of an underlying malignancy. The patient remained
asymptomatic and her examination benign, with no evidence of
hepatosplenomegaly. The decision was made to proceed with an
operation and the patient underwent a laparoscopic splenectomy.
2.1.  Intraoperative ﬁndings
On entering the abdominal cavity signiﬁcant adhesions were
encountered in the region of the inferiolateral aspect of the spleen
where the mass was clearly visible. When the spleen was placed
into a bag for morcellation prior to extraction, it was  noted that the
mass was  signiﬁcantly harder than the rest of the spleen. As a result
the surrounding normal splenic tissue was  morcellated until only
the mass was remaining, and this was then removed in its entirety
and sent for histopathological examination.
2.2. Pathologic ﬁndings
Open access under CC BY-NC-ND license.The  splenic mass was  composed of mutiple nodules of small
vessels surrounded by sclerotic tissue and a scattered lympho-
plasmacytic inﬁltrate. Immunohistochemical staining of the small
BY-NC-ND license.
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Fig. 3. The splenic parenchyma is replaced by innumerable well-circumscribed
angiomatoid nodules separated by a ﬁbrosclerotic and inﬂammatory stroma. The
nodules are composed of a variety of cell types including capillaries, sinusoid-like
spaces,  and mononuclear inﬂammatory cells. Red blood cells are abundant.ig. 1. Computed tomography (CT) scan showing the splenic lesion at the medial
spect  of the lower spleen.
essels within the lesion were positive for CD34, CD31, CD68 and
D163, and negative for CD8 (Figs. 3–7). The histologic sections
nd immunohistochemical staining performed on the splenic lesion
onﬁrmed the diagnosis of SANT of the spleen.
. Discussion
The term SANT ﬁrst appeared in the literature in a 2004
aper by Martel et al. which examined a series of 25 cases.1
his relatively uncommon splenic lesion had however been rec-
gnized earlier by other authors under different names such as
plenic hamartoma, cord capillary hemangioma, and multinodular
emangioma.2 SANTs are benign, nodular vascular proliferations
f splenic red pulp with considerable sclerosis.1,26 It usually affects
iddle-aged adults, and it is commonly found incidentally on
adiographic imaging, or at the time of operation for an unrelated
ondition.20
Review of the existing literature revealed 97 patients consist-
ng of 43 males and 54 females with a median age of 46 years
range: 11–82 years). SANT is considered to be a female predom-
nant disease,26 however 43 of the 97 cases (44.3%) reported in
he literature to date were male and the gender predilection may
oon be neutralized as more cases are reported. 65 out of the 97
67%) patients were in 30–60 year age group, so it appears that
ANT predominantly affects adults in the fourth to seventh decades
f life. The majority of lesions (n = 50) were incidentally found on
ig. 2. Magnetic resonance imaging (MRI) showing the lesion in the lower spleen.
Fig. 4. CD31 immunostain highlights the abundant vascular structures (capillaries,
sinusoid-like  spaces, and veins) along with numerous single cells within the nodules,
generating a complex network of CD31 immunoreactive cells.
Fig. 5. CD34 immunostain highlights the capillaries, but not sinusoid-like spaces or
any single cells.
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Table 1
Published SANT cases.
Author Age Gender Clinical
features
Spleen  weight Gross features Follow-up Referring dx Concurrent
disease
1 Martel1
N = 25
50  Female Incidental
ﬁnding at
laparotomy
329 g – NED, 9 years –
2 32 Female Incidental
radiographic
ﬁnding
139 g 5 cm mass with
white ﬁbrous
bands
NED,  8 years Hamartoma
3 57 Male Incidental
radiographic
ﬁnding
– 3.7 cm ﬁbrotic
mass
NED,  6 years Hemangioma vs. angiosarcoma
4  58 Female Incidental
radiographic
ﬁnding
456 g 9 cm ﬁrm mass NED, 5 years Hemangioma vs. IPT
5 35 Female Pancytopenia,
raised ESR
– 8 cm well-
circumscribed
mass
NED,  4 years Hemangioma
6  71 Female Incidental
radiographic
ﬁnding
704 g 13.5 cm well-
circumscribed
ﬁbrotic  mass
NED, 4 years Hemangioma vs. IPT
7  23 Male 280 g 7 cm well-
circumscribed
ﬁbrotic  mass
NED, 3 years –
8 59 Female Incidental
ﬁnding at
laparotomy
130 g 4 cm ﬁbrotic
mass
NED,  4 years Angiosarcoma vs. IPT
9  37 Female Abdominal
pain
280 g 6 cm mass NED, 1 year Hemangioma vs. littoral cell
angioma
10 29 Male Abdominal
pain
–  10 cm mass NED, 2 years Hemangioma vs. IPT
11 60 Female  – 1400 g 12 cm mass NED, 10 m –
12 74 Male Incidental
ﬁnding at
laparotomy
160 g 3 cm well-
circumscribed
multilobulated
mass
NED,  6 m Hemangioma Renal cell
carcinoma
13 57 Female Incidental
ﬁnding at
laparotomy
173 g 8 cm mass NED, 6 m Vascular tumor
14 61 Female Splenomegaly 68 g 3.5 × 3.5 cm
sharply
demarcated,
gray-white to
red-purple
mass
–  –
15 56 Female Abdominal
discomfort,
anemia
189 g 5.5 cm well-
circumscribed
mass  with
red-brown
nodules
traversed by
stellate  ﬁbrous
bands
NED.  Died of
lung  ca
IPT
16  46 Male Hx of anemia
and  lung SCC.
Presented with
fever  and
splenomegaly
–  – Died of sepsis
post
splenectomy
Bacillary  angiomatosis vs.
Kaposi sarcoma
17 68 Female Carcinoma of
colon  8 m prior
with post-op
chemo.
Incidental
ﬁnding
285 g 4.5 cm
bosselated
whitish  mass
surrounded by
brown  nodules
NED, 7 years Benign Kaposi-like vascular
tumor  vs. bacillary
angiomatosis vs.
chemo-related changes
18  63 Male RUQ pain.
Incidental
ﬁnding
93 g 4 cm mass NED, 3 years – Early gastric
carcinoma
19 56 Male  Incidental
ﬁnding
–  10 cm
circumscribed
whitish  mass
with  focal
hemorrhage
–  IPT
20 25 Female LUQ mass 335 g 8.5 × 6 × 5 cm
circumscribed,
grayish mass
NED, 3 years IPT vs. sclerosedhemangioma
vs.  Castleman disease
CASE  REPORT  –  OPEN  ACCESS
G.A. Falk et al. / International Journal of Surgery Case Reports 3 (2012) 492– 500 495
Table 1 (Continued)
Author Age Gender Clinical features Spleen
weight
Gross features Follow-up Referring dx Concurrent
disease
21 45 Male Incidental
ﬁnding
322 g circumscribed
ﬁrm,
gray-white
nodule with
brown  patches
NED, 3 yearss Hemangioendothelioma vs. IPT
22 43 Female Incidental
ﬁnding
250 g – NED, 2 m N/A
23  35 Female LUQ pain for 6
months
240  g 3.1 × 2.5 cm
subcapsular
mass,  pale,
sclerotic in
center  and
brown-red at
periphery
– Hemangioepithelioma vs.
Kaposi sarcoma
24 23 Female Palpable mass 1425 g 17 × 11 cm
irregular
ﬁbrous mass
with  thick
capsule
NED, 1 year Sclerosedhemangioma vs.
hamartoma
von Willebrand
disease
25 57  Female 105 g 3.5 × 3.4 × 3.2 cm
mass with
multiple dark
red  nodules
NED, 18 m Hemangioma
26  Li3
N = 1
59  Male Incidental
ﬁnding on CT
during  workup
for  renal
problems
283  g 3.3 × 3.3 cm
ﬁrm  yellow
mass
HTN,  DM,
hypothy-
roidism,
BPH
27  J.-C. Lee10
N = 1
43  Female Weight loss
and  left ﬂank
pain
180  g 3.5 × 3.5 × 3.0 cm
and
3.0 × 2.0 × 2.0 cm
Hemorrhagic
nodules
Thrombosedhemangioma,
lymphoma,  chronic abscess
Hepatitis  B+
28  D. Lee4
N = 1
58  Male Incidental
ﬁnding on U/S.
Deranged LFTs
205  g 8.7 × 6.5 × 5.5 cm Metastatic melanoma to spleen Previous
malignant
melanoma
29 Weinreb5
N = 6
58  Female Lung Ca staging
CT
110  g 1.9 cm NED, 1 year SANT
30  65 Male 320 g 6.5 cm Lost to f/u Hamartoma
31  73 Female Hypertension,
hyperlipi-
demia, remote
lung  abscess,
chronic cough
324  g 6.0 cm NED, 16 m Hemangioendothelioma
32  51 Male Anemia 2720 g 12.0 cm NED, 5 m IPT
33 41  Female Enlarging mass
on  serial U/S
256  g 6.5 cm NED, 1 m SANT
34  59 Female Multiple
splenic lesions
20  years post
Whipple for
periampullary
Ca
– 2.1 cm NED, 1 year IPT
35  Diebold11
N = 16
56  Female 2400 g 3 nodules 1.0,
2.0  and 3.0 cm
Idiopathic
myeloﬁbrosis
36  22 Female 220 g 5.5 × 3.0 cm
multinodular
Acute
pyelonephritis
37  37 Female 590 g 10.0 × 7.0 cm
multinodular
38  33 Female Hypochromic
anemia
1760 g multinodular
39  60 Female 430 g 10.0 cm
multinodular
40  44 Male Longstanding
fever
610 g 15.0 cm
multinodular
41  24 Female Hypochondral
pain
160 g 5.0 cm
multinodular
42  Male Gastric ulcer 218 g 1.0 cm
43 31 Female 180 g 7.0 cm
multinodular
44  46 Male Thrombocytopenia 137 g 4.0 cm
multinodular
45  82 Male – 2.0 cm
multinodular
Colon
carcinoma  with
mets  to splenic
hilum
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Table 1 (Continued)
Author Age Gender Clinical
features
Spleen  weight Gross features Follow-up Referring dx Concurrent
disease
46 53 Male 190 g 5.0 cm
multinodular
47  63 Female Fever, night
sweats
140 g 1.5 × 1.0 × 1.0 cm
multinodular
48  55 Male Anemia 550 g 8.0 cm
multinodular
49  62 Female Abdominal
pain
4.0 cm
multinodular
50 50 Male Anemia 840 g 9.0 cm
multinodular
51  El Demellawy12
N = 1
58  Female Incidental
ﬁnding. Hx of
RUL  non-small
cell  carcinoma
stage III
110 g 1.9 cm well-
circumscribed
but  non-
encapsulated
nodule.
Bosselated
contour and
whitish, ﬁrm,
solid  surface
Metastatic lung cancer
52  Karaosmanoglu13
N = 1
44  Male Vague pelvic
pain
650 g Whitish ﬁrm
nodule  with
hemorrhagic
spiculations
53  Zeeb14
N = 1
36  Female LUQ Pain for 2
weeks
Multiple
red-brown
nodules with a
prominent
stellate  scar
54 Teng15
N = 1
37  Female Incidental
ﬁnding with
hepatolitiasis
1080 g 8.5 × 8.5 cm
55 31 Male Incidental
ﬁnding
780 g 8.0 × 8.0 cm
56 58 Female Flank/back pain
for  1 month
528 g 6.5 × 4.5 cm
57 31 Female Upper
abdominal
discomfort × 2
years
2106 g 8.5 × 8.5 cm SANT
58 37 Male Incidental
ﬁnding
297 g 3.0 × 3.0 cm SANT
59 37 Male Incidental
ﬁnding
473 g 3.5 × 3.0 cm SANT
60 50 Female Incidental
ﬁnding with
hepatic
angioma
314 g 2.6 × 2.4 cm SANT
61 Kashiwagi16
N = 9
31  Female Incidental
Finding
230 g 5.5 cm – IPT
62 34 Male Back
discomfort
–  7.0 cm NED, 3 m IPT
63 37 Male Epigastric pain 80 g 3.0 cm NED, 79 m IPT
64 44 Female Incidental
Finding
–  3.5 cm NED, 25 m SANT Cholelithiasis
65  46 Male Incidental
Finding
110 g 6.5 cm – IPT Chronic
hepatitis
66  50 Male Incidental
Finding
500 g 11.0 cm – IPT
67 60 Male Incidental
Finding
100 g 2.5 cm NED, 37 m SANT Gastric cancer
68  65 Female Incidental
Finding
–  5.1 cm – IPT Cholelithiasis
69  72 Female Incidental
Finding
–  2.0 cm NED, 113 m IPT Colon cancer
70  Gutzeit17
N = 1
77  Male Incidental
ﬁnding on CT.
Patient  had
prostate cancer
8 × 6 cm Hamartoma
71 Koreishi6
N = 3
58  Female Abdominal
pain
307 g 4.4 cm in
inferior  pole
NED; Alive DM,
hypothyroidism
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Table 1 (Continued)
Author Age Gender Clinical
features
Spleen weight Gross features Follow-up Referring dx Concurrent
disease
72 72 Female Incidental
ﬁnding or
annual  CT scan
79  g 2.3 cm NED; Alive Hx of
high-grade
urothelial
carcinoma of
renal  pelvis
and  low-grade
urothelial
carcinoma of
bladder
73  64 Female Incidental
ﬁnding on
routine CT scan
110  g 2.1 cm NED; Alive Hx of
carcinoma of
fallopian  tube,
malignant
melanoma in
situ
74  Langer18
N = 1
44  Male Incidental
ﬁnding on
routine CT scan
170  g 2.0 cm mass;
encapsulated
reddish
nodular
NED 4 m; Alive Metastatic
rectal cancer
75  Chikkappa19
N = 1
40  Female Intermittent
LUQ pain
168  g 4.7 × 4.0 × 6.5 cm
peripheral
circumscribed
nodule, which
was  partly
ﬁbrous and
partly  nodular
hemorrhagic
SANT
76 Thacker20
N = 1
80  Male Incidental
radiographic
ﬁnding
– Granular and
gray-purple
with  a
lobulated 9 cm
mass with
hemorrhagic
areas
measuring
0.1–0.5 cm
SANT MDS,
Melanoma,
Basal cell
carcinoma and
squamous  cell
carcinoma
77 Kuybulu21
N = 1
11  Female Incidental
ﬁnding on
physical
examination
Well
circumscribed
conﬂuent
vascu-
lar/angiomatoic
nodules  with
mixed-type
inﬂammatory
cells
NED, 1 year SANT Short stature
78  Kuo22
N = 10
32  Female Left ﬂank
soreness for 2
weeks
139  g Single
3 × 4 × 5 cm
nodule
NED, 94 m SANT
79  53 Female Diffuse
abdominal pain
– Single 3 × 3 cm
nodule
NED, 166 m SANT
80  57 Female Incidental
ﬁnding
105 g Single
3.5 × 3.4 × 3.2 cm
nodule
– SANT
81  37 Male Incidental
ﬁnding
275 g Single 6 × 6 cm
nodule
– SANT
82  46 Female RUQ pain for 2
months
104  g Single
2.2 × 2 × 2 cm
nodule
– SANT
83 39 Male Incidental
ﬁnding
278 g Multinodular NED, 14 m SANT
84  31 Male Right inguinal
mass  and
Incidental
radiographic
ﬁnding
654  g Multinodular NED, 6 m SANT
85  57 Male Left upper
abdominal pain
for  2 years
142.5 g Multinodular – SANT
86  33 Female LUQ Pain for 1
year
143.6  g Single
5.2 × 5 × 4 cm
NED, 2 m SANT
87 44 Male Incidental
ﬁnding
212.6 g Single
6.8 × 6 × 4.5 cm
NED, 1 m SANT
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Table 1 (Continued)
Author Age Gender Clinical
features
Spleen  weight Gross features Follow-up Referring dx Concurrent
disease
88 Cao23
N = 3
36  Male Incidental
radiographic
ﬁnding
–  Mass was
found to have
an  integrated
envelope and a
heterogenous
cut  surface
SANT
89 37 Female Pain in the LUQ – Firm mass with
a  clear margin
SANT
90 39 Male LUQ mass – – SANT
91 Sitaraman24
N = 1
65  Male Incidental
radiographic
ﬁnding
750 g 2 cm well-
circumscribed
nodule  with an
area  of central
ﬁbrosis
SANT Retroperitoneal
spindle cell
sarcoma
92 Subhawong25
N = 1
27  Female RUQ pain after
motor  vehicle
crash
474 g 10.2 cm ﬁrm,
white,  nodular
lesion
inﬁltrating red
irregularly
SANT Unexplained
anemia with
history  of
transfusion
93  Bamboat26
N = 1
17  Male Abdominal
pain for 6
months
Lobulated 4 cm
ﬁbrotic mass
with
hemorrhagic
areas
NED,  7 m SANT
94 Raman27
N = 1
50  Male LUQ pain for 4
months
95  Ki-Han28
N = 1
23  Female Incidental
radiographic
ﬁnding
–  5.2 × 4.5 cm
dark  brown
mass with a
central  large
stellate ﬁbrotic
scar
SANT
96 Onder29
N = 1
48  Male Pelvic pain 650 g 8 cm solitary
non-
encapsulated
mass
composed  of
multiple
nodules  with
wide  area of
hemorrhage
and  a central
stellate scar
SANT
97 Vyas30
N = 1
11  Male Left ﬂank pain
since  2 months
125 g 5 × 4 × 4 cm
well-
circumscribed
unencapsu-
lated lesion
with  bulging
cut  s
centr
scar
NED,  3 years SANT
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amaging, and for those patients presenting with symptoms,
bdominal pain (n = 18) was the predominant symptom. Other
resentations included: a palpable left upper quadrant mass;
ytopenias; ﬂank pain; pelvic pain; and long-standing fever.
The  weight of resected spleens in the literature exhibited sig-
iﬁcant variation from 68 to 2720 g. The typical macroscopic
ppearance of a SANT lesion was of a well-circumscribed non-
ncapsualted, bosselated mass with multiple dark brown nodules
hemorrhagic regions in angiomatoid nodules) interspersed with
tellate whitish ﬁbrotic stroma.1,26,27 The cases reported before
008 had varying diagnoses that included hamartoma, inﬂamma-
ory pseudotumor, hemangioma, angisarcoma, metastatic tumor,
acillary angiomatosis, but thereafter SANT has been the referring
iagnosis.There is minimal data available on the follow-up of patients with
ANT. There are two reported deaths in the 25 cases published by
artel et al.1; a 56-year-old female who died of disseminated lung
denocarcinoma, and the other a 46-year-old male with concurrenturface and
al  ﬁbrotic
bronchogenic squamous cell carcinoma who died of sepsis post-
splenectomy. There is no data regarding the immunization status
and use of antibiotic prophylaxis in these patients (Table 1).
There  is currently no pathognomonic ﬁnding for the diagnosis of
SANT on cross-sectional imaging, however, the literature suggests
that the diagnosis can be made if a contrast-enhanced MRI shows
a “spoke-wheel pattern”.20,26 Gutzeit et al.17,23 propose the use of
contrast-enhanced ultrasonography (CEUS) to diagnose SANT, but
the role of CEUS needs to be further evaluated as data is limited.
There have been two  reports of F-18 ﬂuorodeoxyglucose (FDG)-
avid splenic lesions found to be SANT lesions,20 however other
authors have reported SANT cases without PET activity.6
Martel et al. found three distinct types of blood vessels in the
specimens they examined, mirroring the normal composition of
1splenic red pulp. The ﬁrst were well-formed cord capillaries in
an organized lobular arrangement that were CD34+/CD8−/CD31+.
The second type of vessel were consistent with splenic sinusoids
and were CD34−/CD8+/CD31+. The third type consisted of small
CASE  REPORT  –  O
G.A. Falk et al. / International Journal of Su
Fig. 6. CD8 immunostain highlights occasional sinusoid-like spaces (lower right)
and scattered inﬂammatory cells, but is absent in other vascular structures (capil-
laries  and veins).
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(SANT) of the spleen: addition of a case with focal CD68 staining and distinctiveig. 7. CD68 immunostain highlights scattered single cells (presumably histiocytes)
ut  no vessel-lining cells.
eins arranged in a very intricate mesh-like patterns, and were
D34−/CD8−/CD31+. The nodules of vessels are separated by col-
agenous bands, and the stroma between nodules is sclerotic.
As  SANT is a vascular lesion comprised of an over-proliferation
f blood vessels, its differential diagnosis includes other benign
esions such as hamartomas, hemangiomas, hemangioendothe-
iomas, littoral cell angiomas, or inﬂammatory myoﬁbroblastic
esions. Martel et al. noted that the pathogenesis of this entity is
nclear and hypothesize that SANT may  be a splenic hamartoma
hat has undegone an unusual form of sclerosis, with a peculiar
eactionary transformation of red pulp due to an exaggerated stro-
al  response.1 It appears that SANT is probably a reactive lesion
ather than a true neoplastic process, a theory supported by the
igh prevalence of concurrent conditions in SANT patients.
The  fact that SANT can resemble an inﬂammatory pseudotu-
our has prompted some authors to suggest that the two lesions
ay in fact be the same.5 In support of this hypothesis there have
een reports of SANT cases which show EBER-1 (Epstein–Barr virus-
ncoded small RNAs) positive stromal cells.5 However, while the
troma of IPT and SANT may  be histologically similar, IPT do not
ontain the angiomatoid nodules seen in SANT.8 Recently a num-
er of authors have suggested that the proliferation seen in SANTPEN  ACCESS
rgery Case Reports 3 (2012) 492– 500 499
may  be related to IgG4 sclerosing lesions due to the presence of
plasma cells found in its stroma.6,7
As this lesion is benign without risk of malignant transforma-
tion, the question arises whether an asymptomatic patient with
SANT should undergo an operative procedure if the lesion is found
incidentally? There is currently no sensitive and speciﬁc way to
make a diagnosis of SANT without having a tissue sample, and as
some lesions that resemble SANT are malignant in nature, we  think
it prudent to operate even if SANT is suspected. Core biopsy is a
sensitive and speciﬁc way to diagnose both hematologic and non-
hematologic splenic lesions.8,9 Weinreb et al. argue that due to its
distinctive nodular pattern, lack of atypia, and unique immunohis-
tochemical proﬁle, that core biopsy can be used to distinguish SANT
from other lesions in the differential diagnosis of SANT.5 However,
an important factor which Weinreb et al. do not appear to consider,
is the risk of intra-peritoneal seeding if the lesion being biopsied
proves to be say an angiosarcoma.5
4. Conclusion
The diagnosis of SANT should be considered in any patient
presenting with a splenic lesion that contains an angiomatoid or
inﬂammatory component. There is a wide age distribution and the
gender distribution appears to be equal. The majority of cases of
SANT reported in the literature were incidental diagnoses, with
the remainder presenting with a variety of non-speciﬁc symptoms.
As the differential diagnosis for SANT includes malignant patholo-
gies, and currently no reliable diagnostic radiological feature has
been identiﬁed to differentiate between these conditions, SANT will
continue to be diagnosed on the basis of surgical histopathology.
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